Research Topics
Genomes and Genes
| Alfred H SchinkelSummaryAffiliation: The Netherlands Cancer Institute Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Murine oatp1a/1b uptake transporters control rosuvastatin systemic exposure without affecting its apparent liver exposureDilek Iusuf
Division of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Mol Pharmacol 83:919-29. 2013....
Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouseWolfgang Kummer
Institute for Anatomy and Cell Biology, Justus Liebig University, 35385 Giessen, Germany
Respir Res 7:65. 2006..Hence, the hypothesis emerged that 5-HT evokes bronchoconstriction by inducing release of ACh from epithelial cells via OCTs...
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overviewAlfred H Schinkel
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Adv Drug Deliv Rev 55:3-29. 2003..We aim to provide an overview of properties of the mammalian ABC transporters known to mediate significant transport of clinically relevant drugs...
Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milkAntonius E van Herwaarden
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Mol Cell Biol 27:1247-53. 2007..This study establishes the principle that an ABC transporter can transport a vitamin into milk and raises the possibility that other vitamins and nutrients are likewise secreted into milk by ABC transporters...
Polymorphisms affecting function of the human organic cation transporter hOCT1 (SLC22A1): what are the consequences?Alfred H Schinkel
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Pharmacogenetics 12:589-90. 2002
Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1)Evita van de Steeg
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Drug Metab Dispos 37:277-81. 2009..SLCO1B1 transgenic mice could be a useful tool in studying the in vivo role of human OATP1B1 in drug pharmacokinetics...
Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivoMaria L H Vlaming
Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Mol Cancer Ther 8:3350-9. 2009..Nevertheless, cotreatment with possible inhibitors of ABCC2, ABCC3, and ABCG2 should be done with utmost caution when treating patients with methotrexate...
Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivoMaria L H Vlaming
Divisions of Molecular Biology, The Netherlands Cancer Institute, The Netherlands
Clin Cancer Res 15:3084-93. 2009..We investigated the possibly overlapping roles of Abcg2 and Abcc2 in the elimination of the anticancer drug methotrexate (MTX) and its toxic metabolite 7-hydroxymethotrexate (7OH-MTX)...
Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milkAntonius E van Herwaarden
Division of Experimental Therapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
Carcinogenesis 27:123-30. 2006..Paradoxically, Bcrp1/BCRP appears to have both protective and adverse roles with respect to exposure to dietary carcinogens...
The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patPauline Breedveld
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Cancer Res 65:2577-82. 2005..o. imatinib increased 5.2-fold when pantoprazole was co-administered in wild-type mice. Our results suggest that co-administration of BCRP and P-gp inhibitors may improve delivery of imatinib to malignant gliomas...
Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolamRobert A B van Waterschoot
Division of Molecular Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
Drug Metab Dispos 37:2305-13. 2009..The data clarify that for drugs that are not P-glycoprotein substrates, intestinal metabolism also can be more important than hepatic metabolism after oral administration...
Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicityRobert A B van Waterschoot
Divisions of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Cancer Res 69:8996-9002. 2009..Simultaneous inhibition of CYP3A/P-gp might thus be a highly effective strategy to improve oral drug bioavailability but with serious risks when applied to drugs with narrow therapeutic windows...
Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactionsPauline Breedveld
Divisions of Experimental Therapy, Molecular Biology, Clinical Chemistry, and Medical Oncology, The Netherlands Cancer Institute, Amsterdam
Cancer Res 64:5804-11. 2004..v. MTX in wild-type mice. The conclusion is as follows: benzimidazoles differentially affect transport of MTX mediated by BCRP and MRP2. Competition for BCRP may explain the clinical interaction between MTX and benzimidazoles...
Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministrationSeng Chuan Tang
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Int J Cancer 130:223-33. 2012..Complete inhibition of both transporters, leading to markedly increased brain accumulation of sunitinib, is feasible and safe with a clinically realistic oral elacridar/sunitinib coadministration...
Breast cancer resistance protein and P-glycoprotein limit sorafenib brain accumulationJurjen S Lagas
Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Mol Cancer Ther 9:319-26. 2010....
The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milkJohan W Jonker
The Netherlands Cancer Institute, Division of Experimental Therapy, Amsterdam, The Netherlands
Nat Med 11:127-9. 2005....
P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycinJurjen S Lagas
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
Antimicrob Agents Chemother 52:1034-9. 2008..Individuals with reduced or absent P-gp activity could therefore be more susceptible to salinomycin toxicity...
In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2Serena Marchetti
Department of Experimental Therapy and Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Mol Cancer Ther 6:3307-13. 2007..Implications of BCRP expression in the gut for the oral development of gimatecan and the interaction between gimatecan and other BCRP substrate drugs and/or inhibitors warrant further clinical investigation...
Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2)Gracia Merino
The Netherlands Cancer Institute, Division of Experimental Therapy, Amsterdam, The Netherlands
Drug Metab Dispos 33:614-8. 2005..The use of efficacious BCRP/Bcrp1 inhibitors might increase the extent and duration of systemic exposure to ABZSO and OXF, with possible therapeutically beneficial effects in extra-intestinal infections...
Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexateMaria L H Vlaming
Divisions of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Clin Cancer Res 14:8152-60. 2008..We investigated the roles of Abcc2 and Abcc3 in the elimination of the anticancer drug methotrexate (MTX) and its toxic metabolite 7-hydroxymethotrexate (7OH-MTX) in vivo...
High impact of Oatp1a/1b transporters on in vivo disposition of the hydrophobic anticancer drug paclitaxelEvita van de Steeg
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Clin Cancer Res 17:294-301. 2011..We investigated the role of Oatp1a/1b transporters in the pharmacokinetics of PTX in vivo, as well as their impact at different dose levels of PTX and methotrexate (MTX)...
Brain accumulation of dasatinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by elacridar treatmentJurjen S Lagas
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Clin Cancer Res 15:2344-51. 2009..For dasatinib, an inhibitor of SCR/BCR-ABL kinases, in vivo interactions with P-gp and ABCG2 are not fully established yet...
Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolismAntonius E van Herwaarden
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Clin Invest 117:3583-92. 2007..The genetic models used in this study provide powerful tools to further study CYP3A-mediated xenobiotic metabolism, as well as interactions between CYP3A and other detoxification systems...
Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of miceJohan W Jonker
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Stem Cells 23:1059-65. 2005..Interestingly, bone marrow of Mdr1a/1b-/- mice frequently displayed an elevated SP, which was reversible by the Bcrp1 inhibitor Ko143, suggesting that Bcrp1 can compensate for the loss of Mdr1a/1b in bone marrow...
The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridineAntonius E van Herwaarden
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Cancer Res 63:6447-52. 2003..Intra- or interindividual differences in BCRP activity in humans may thus also affect the exposure to PhIP and related food carcinogens, with possible implications for cancer susceptibility...
Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liverEvita van de Steeg
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Clin Invest 122:519-28. 2012..Moreover, OATP1B1 and OATP1B3 null mutations may confer substantial drug toxicity risks...
Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2)Christian Zimmermann
Division of Experimental Therapy, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Drug Metab Dispos 36:631-40. 2008..These differences should be taken into account when results obtained in mice are extrapolated to humans...
Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IXJohan W Jonker
Div of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Am J Physiol Cell Physiol 292:C2204-12. 2007..This mechanism may allow cells to prevent or reduce cytotoxicity of PPIX under excess conditions, without spillage under physiological conditions where PPIX is needed...
Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout miceMaria L H Vlaming
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Adv Drug Deliv Rev 61:14-25. 2009..However, the physiological significance of these processes has been difficult to establish, indicating that there is still a lot to learn about this intriguing protein...
Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoproteinJohn D Allen
Division of Experimental Therapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
Cancer Res 63:1339-44. 2003..It may thus be worthwhile to test inhibition of P-gp in humans to improve the oral availability of etoposide...
Assessing safety and efficacy of directed P-glycoprotein inhibition to improve the pharmacokinetic properties of saquinavir coadministered with ritonavirMaarten T Huisman
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Pharmacol Exp Ther 304:596-602. 2003..Clinical attempts to efficiently inhibit P-glycoprotein function for improved HPI disposition may therefore be feasible, but they should be performed without ritonavir and monitored carefully for unexpected toxicities...
Complex pharmacokinetic behavior of ezetimibe depends on abcc2, abcc3, and abcg2Dirk R de Waart
Liver Center, Academic Medical Center, Meibergdreef 69 71, Amsterdam, The Netherlands
Drug Metab Dispos 37:1698-702. 2009..5%) compared with that in wild-type mice. These data demonstrate that the enterohepatic circulation of Ez-gluc strongly depends on the joint function of Abcc3, Abcc2, and Abcg2...
Organic anion-transporting polypeptide 1B1 mediates transport of Gimatecan and BNP1350 and can be inhibited by several classic ATP-binding cassette (ABC) B1 and/or ABCG2 inhibitorsRoos L Oostendorp
The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Drug Metab Dispos 37:917-23. 2009....
P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) restrict brain accumulation of the active sunitinib metabolite N-desethyl sunitinibSeng Chuan Tang
Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
J Pharmacol Exp Ther 341:164-73. 2012..The effect of elacridar treatment in improving brain accumulation of N-desethyl sunitinib in wild-type mice was limited compared with its effect on sunitinib brain accumulation...
Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugsEvita van de Steeg
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Clin Invest 120:2942-52. 2010..Slco1a/1b-/- mice will provide excellent tools to study further the role of Oatp1a/1b transporters in physiology and drug disposition...
Intestinal cytochrome P450 3A plays an important role in the regulation of detoxifying systems in the liverRobert A B van Waterschoot
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
FASEB J 23:224-31. 2009..This broad biological effect further emphasizes the importance of intestinal CYP3A activity and could have profound implications for the prediction of drug exposure...
P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposideJurjen S Lagas
Authors Affiliations Divisions of Molecular Biology and Clinical Chemistry, The Netherlands Cancer Institute, and Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
Clin Cancer Res 16:130-40. 2010..We aimed to study the impact of P-glycoprotein (P-gp/ABCB1) and the multidrug resistance proteins ABCC2 (MRP2) and ABCC3 (MRP3) on the pharmacokinetics of etoposide...
Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transportersJurjen S Lagas
Division Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Mol Pharmacol 77:687-94. 2010..We believe that the handling of diclofenac acyl glucuronides by ATP binding cassette transporters may be representative for the handling of acyl glucuronide metabolites of many other clinically relevant drugs...
Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liverGracia Merino
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam
Mol Pharmacol 67:1765-71. 2005....
Midazolam metabolism in cytochrome P450 3A knockout mice can be attributed to up-regulated CYP2C enzymesRobert A B van Waterschoot
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Mol Pharmacol 73:1029-36. 2008..Such flexible compensatory interplay between functionally related detoxifying systems is probably essential to their biological role in xenobiotic protection...
Differential impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on axitinib brain accumulation and oral plasma pharmacokineticsBirk Poller
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Drug Metab Dispos 39:729-35. 2011..These findings illustrate that in vitro transport data for ABCB1 and ABCG2 cannot always be simply extrapolated to the prediction of the relative impact of these transporters on oral availability versus brain penetration...
Organic anion-transporting polypeptides 1a/1b control the hepatic uptake of pravastatin in miceDilek Iusuf
Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Mol Pharm 9:2497-504. 2012..Activity-reducing human OATP1B polymorphisms may therefore both reduce pravastatin therapeutic efficacy in the liver and increase systemic toxicity risks, thus compromising its therapeutic index in a two-edged way...
Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronidesKoen van de Wetering
Division of Molecular Biology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Mol Pharmacol 72:387-94. 2007..Our results show that murine Mrp2 and Mrp3 provide alternative routes for the excretion of a glucuronidated substrate from the liver in vivo...
MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecidMaarten T Huisman
Division of Experimental Therapy, Netherlands Cancer Institute, Amsterdam, The Netherlands
Int J Cancer 116:824-9. 2005....
An integrated pharmacokinetic model for the influence of CYP3A4 expression on the in vivo disposition of lopinavir and its modulation by ritonavirRob ter Heine
Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands
J Pharm Sci 100:2508-15. 2011..Hepatic CYP3A4 related systemic clearance was inversely related to ritonavir exposure and not only hepatic but also intestinal CYP3A4 expression contributed to systemic clearance of lopinavir...
Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokineticsJurjen S Lagas
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Clin Cancer Res 12:6125-32. 2006..Variation in MRP2 activity might thus directly affect the effective exposure to paclitaxel, on i.v. administration, but also on oral administration, especially when P-gp activity is inhibited...
Impact of abcc2 [multidrug resistance-associated protein (MRP) 2], abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexateMaria L H Vlaming
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Drug Metab Dispos 39:1338-44. 2011..Such conditions may also present risk factors for increased MTX-related toxicity in patients treated with oral MTX...
Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromaroneJurjen S Lagas
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Drug Metab Dispos 37:129-36. 2009..Moreover, stimulation of MRP2 activity in tumors may lead to increased efflux of chemotherapeutic drugs and thereby drug resistance...
The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoinGracia Merino
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam
Mol Pharmacol 67:1758-64. 2005..We conclude that Bcrp1 is an important determinant for the bioavailability of nitrofurantoin and the main mechanism involved in its hepatobiliary excretion and secretion into the milk...
Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrierBirk Poller
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Mol Pharm 8:571-82. 2011..MDCKII-ABCB1/ABCG2 cells thus present a useful in vitro model to study the interplay of ABCB1 and ABCG2...
Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxelRobert A B van Waterschoot
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Int J Cancer 127:2959-64. 2010..These findings could have important implications for improving the oral bioavailability and reducing the variability in docetaxel exposure...
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin CJohn D Allen
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam
Mol Cancer Ther 1:417-25. 2002..As such, Ko143 and other FTC analogues of this type represent valuable reagents for analysis of drug resistance mechanisms and may be candidates for development as clinical BCRP inhibitors...
Midazolam and cyclosporin a metabolism in transgenic mice with liver-specific expression of human CYP3A4Antonius E van Herwaarden
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Drug Metab Dispos 33:892-5. 2005..We expect that this CYP3A4 transgenic model will provide a useful tool to study the impact of CYP3A4 on drug levels, especially when combined with other transgenic and knockout strains...
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyriaJohan W Jonker
Division of Experimental Therapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
Proc Natl Acad Sci U S A 99:15649-54. 2002....
PXR-mediated induction of human CYP3A4 and mouse Cyp3a11 by the glucocorticoid budesonideChristian Zimmermann
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Eur J Pharm Sci 36:565-71. 2009..Therefore, the risk for budesonide-mediated drug interactions seems to be low but cannot be ruled out entirely...
The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxinsAntonius E van Herwaarden
Division of Experimental Therapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
Trends Pharmacol Sci 27:10-6. 2006..In apparent contradiction with the detoxifying role of BCRP in mothers, this contamination of milk exposes suckling infants and dairy consumers to xenotoxins. BCRP thus affects many important aspects of pharmacology and toxicology...
Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2)Noam Zelcer
Division of Molecular Biology and Center of Biomedical Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands
J Biol Chem 278:23538-44. 2003..We propose that MRP2 contains two similar but nonidentical ligand binding sites: one site from which substrate is transported and a second site that regulates the affinity of the transport site for the substrate...
A sensitive assay for the quantitative analysis of vinorelbine in mouse and human EDTA plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometryCarola W N Damen
Department of Pharmacy and Pharmacology, Slotervaart Hospital The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Chromatogr B Analyt Technol Biomed Life Sci 868:102-9. 2008..The lower limit of quantification in mouse plasma is 0.8 ng/mL. This assay is used to support preclinical and clinical pharmacologic studies with vinorelbine...
Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugsMaarten T Huisman
Division of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
AIDS 16:2295-301. 2002..MRP2 function and enhancement of its activity could adversely affect the therapeutic efficacy, including the pharmacological sanctuary penetration, of HPI. In vivo inhibition of MRP2 function might, therefore, improve HIV/AIDS therapy...
How important is intestinal cytochrome P450 3A metabolism?Antonius E van Herwaarden
Division of Molecular Biology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
Trends Pharmacol Sci 30:223-7. 2009..We expect that the insights obtained with these mouse models will contribute to the development of better oral drugs and treatment regimens...
P-glycoprotein (ABCB1) transports the primary active tamoxifen metabolites endoxifen and 4-hydroxytamoxifen and restricts their brain penetrationDilek Iusuf
The Netherlands Cancer Institute, Division of Molecular Biology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
J Pharmacol Exp Ther 337:710-7. 2011..P-gp might thus be relevant for tamoxifen/endoxifen resistance of P-gp-positive breast cancer and tumors positioned behind a functional blood-brain barrier...
A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometryJeroen J M A Hendrikx
Department of Pharmacy and Pharmacology, Slotervaart Hospital The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Chromatogr B Analyt Technol Biomed Life Sci 879:2984-90. 2011..The described method was successfully applied in clinical studies with oral administration of docetaxel or paclitaxel in combination with ritonavir...
Pharmacokinetic assessment of multiple ATP-binding cassette transporters: the power of combination knockout miceJurjen S Lagas
Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Mol Interv 9:136-45. 2009..In addition, the characterization of these mice and some physiological aspects of ABC multidrug transporters are addressed...
A critical analysis of the interplay between cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic miceRobert A B van Waterschoot
Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Pharmacol Rev 63:390-410. 2011..Above all, the recent findings and insights into the interplay between CYP3A and P-glycoprotein may have implications for improving oral drug bioavailability and reducing adverse side effects...
Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2)Karin Mohrmann
Division of Experimental Therapy, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
Cancer Chemother Pharmacol 56:344-50. 2005..However, BCRP-N557A and the triple mutant were mainly localized intracellularly, probably in the endoplasmic reticulum, suggesting that this mutation disrupted proper routing of BCRP...
Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cationsJohan W Jonker
Division of Experimental Therapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
Mol Cell Biol 23:7902-8. 2003..This study shows that Oct1 and Oct2 together are essential for renal secretion of (small) organic cations. A deficiency in these proteins may thus result in increased drug sensitivity and toxicity...
Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3)Johan W Jonker
The Netherlands Cancer Institute, Division of Experimental Therapy, Amsterdam, The Netherlands
J Pharmacol Exp Ther 308:2-9. 2004....
A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistanceJohn D Allen
Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Cancer Res 62:2294-9. 2002..The same is most likely true of human BCRP, given its profound similarities to mouse Bcrp1...
Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretionGracia Merino
Department of Physiology, Faculty of Veterinary Medicine, , Campus de Vegazana, , Spain
Drug Metab Dispos 34:690-5. 2006..We conclude that Bcrp1 is one of the determinants for the bioavailability of fluoroquinolones and their secretion into the milk...
Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance proteinYoung-Joo Lee
Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
J Pharmacol Exp Ther 312:44-52. 2005....
Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidinePetr Pavek
Department of Pharmacology and Toxicology and Research Center, Charles University in Prague, Faculty of Pharmacy, Hradec, , The Czech Republic
J Pharmacol Exp Ther 312:144-52. 2005..The generated BCRP-expressing cell lines thus provide valuable tools to study pharmacological and toxicological interactions mediated by BCRP and to identify new BCRP substrates...
Involvement of multiple efflux transporters in hepatic disposition of fexofenadineSoichiro Matsushima
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7 3 1 Hongo, Bunkyo ku, Tokyo 113 0033, Japan
Mol Pharmacol 73:1474-83. 2008..On the other hand, pharmacokinetics of FEX remained unchanged in Mrp4(-/-) mice. This information provides a novel insight into the transporters important for FEX disposition...
Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolonesTomohiro Ando
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan
Drug Metab Dispos 35:1873-9. 2007..The present study shows that BCRP mediates the biliary excretion of fluoroquinolones and suggests that it is also involved in the tubular secretion of ciprofloxacin and grepafloxacin...
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metforminDe Sheng Wang
Graduate School of Pharmaceutical Sciences, University of Tokyo, 7 3 1 Hongo, Bunkuo ku, Tokyo 113 0033, Japan
J Pharmacol Exp Ther 302:510-5. 2002....
Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levelsElke Schneider
UMR 8147, Centre National de la Recherche Scientifique, Faculté de Médecine René Descartes, Paris V, Hopital Necker, 75015 Paris, France
J Exp Med 202:387-93. 2005..We postulate that pharmacologic modulation of histamine transport might become instrumental in the control of basophil functions during allergic diseases...
P glycoprotein in human immunodeficiency virus type 1 infection and therapySanjay U C Sankatsing
Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Center, University of Amsterdam, The Netherlands
Antimicrob Agents Chemother 48:1073-81. 2004
Involvement of organic cation transporter 1 in the lactic acidosis caused by metforminDe-sheng Wang
Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan
Mol Pharmacol 63:844-8. 2003....
Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compoundsJunichi Enokizono
Graduate School of Pharmaceutical Sciences, University of Tokyo, 7 3 1, Hongo, Bunkyo ku, Tokyo 113 0033, Japan
Drug Metab Dispos 36:995-1002. 2008..These results suggest that BCRP limits the tissue penetration of xenobiotic compounds in the blood-brain and -testis barriers, but its in vivo importance is also modulated by P-glycoprotein activity...
Role of breast cancer resistance protein (Bcrp1/Abcg2) in the extrusion of glucuronide and sulfate conjugates from enterocytes to intestinal lumenYasuhisa Adachi
Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7 3 1, Hongo, Bunkyo ku, Tokyo 113 0033, Japan
Mol Pharmacol 67:923-8. 2005..Therefore, Bcrp1 has an important role in extruding glucuronide and sulfate conjugates formed in enterocytes into the intestinal lumen, whereas Mrp2 is responsible for the efflux of some glucuronide conjugates...
Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2)John D Allen
The Centenary Institute of Cancer Medicine and Cell Biology, Newtown, NSW, Australia
Mol Cancer Ther 1:427-34. 2002
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics studyJacques Fellay
Division of Infectious Diseases, University Hospital of Lausanne, Lausanne, Switzerland
Lancet 359:30-6. 2002..This variability could have a genetic basis. We did a pharmacogenetics study to analyse the association between response to antiretroviral treatment and allelic variants of several genes...
